Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02714140 · ClinicalTrials.gov registry record · NA
Does Preference-based HIV Testing Increase Uptake in High Risk Populations?
A NA study, sponsored by University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 1,194
- Enrollment target
NCT02714140: Completed NA study, sponsored by University of South Carolina.
NCT02714140 is a NA study that has completed, run by University of South Carolina. The registered enrollment target is 1,194 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (15% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02714140, a NA study, has completed, sponsored by University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,194 participants
- Enrollment target
Study Summary
Despite worldwide efforts to promote HIV Counseling and Testing (HCT), rates of testing remain low. Understanding how high risk groups decide to test and adapting available testing options to their preferences has the potential to broadly improve HCT uptake and cost-effectiveness. This study proposes to use a Discrete Choice Experiment, a survey method increasingly used by health economists for the design of patient-centered health care options, to rigorously quantify HIV testing preferences among two high-risk populations, identify their preferred testing options, and evaluate, in a pragmatic randomized controlled trial (RCT), the effect of a preference-based HIV counseling and testing (PB-HCT) intervention on testing uptake. At a time of heightened focus on health preferences research and patient-centered care, this study evaluates the critical link between preference-based intervention design and efficacy. If the RCT indicates that PB-HCT increases testing rates, the testing options evaluated in this R01 can be offered to high-risk populations in the study area, and the preference elicitation method and tools can be used to inform the design of testing options that better match the preferences of other high-risk populations and in other settings.
Primary Outcome
Percent of participants who test for HIV
Interventions
- BEHAVIORAL PB-HCT +
- BEHAVIORAL PB-HCT -
- BEHAVIORAL Economic incentive
- BEHAVIORAL PB-HCT ++
- BEHAVIORAL SMS Reminder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,194 participants |
| Start Date | 2018-01-03 |
| Est. Completion | 2020-10-31 |
| Phase | NA |
What the finished NCT02714140 record still lists
NCT02714140 is an interventional study that assigns participants to a tested intervention. Its 1,194 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (15% lower).
The record links to 0 conditions, and to 5 interventions - of which PB-HCT + is the first listed.
NCT02714140 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02714140 about?
NCT02714140 is a clinical study titled "Does Preference-based HIV Testing Increase Uptake in High Risk Populations?". Despite worldwide efforts to promote HIV Counseling and Testing (HCT), rates of testing remain low. Understanding how high risk groups decide to test and adapting available testing options to their preferences has the potential to broadly improve HCT uptake and cost-effectiveness. This study propose...
What is the current status of trial NCT02714140?
This trial is currently completed. It is a NA study. The enrollment target is 1,194 participants. The study started on 2018-01-03. Estimated completion is 2020-10-31.
What interventions are being tested in trial NCT02714140?
The interventions under investigation include: PB-HCT + (BEHAVIORAL), PB-HCT - (BEHAVIORAL), Economic incentive (BEHAVIORAL), PB-HCT ++ (BEHAVIORAL), SMS Reminder (BEHAVIORAL).
Who is sponsoring clinical trial NCT02714140?
This trial is sponsored by University of South Carolina, which has 157 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02714140's enrollment target sits among peer trials
1,194 89th of 2000 higher than 1,912 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07177339 · 1,196 participants · Phase 3
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- NCT00001987 · 1,200 participants
Genetic Studies of Insulin and Diabetes
- NCT00477100 · 1,200 participants
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
- NCT01209000 · 1,200 participants
Nephrotic Syndrome Study Network
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI